Does dopamine still have a leading role in advanced Parkinson's disease after subthalamic stimulation?

Stereotactic and Functional Neurosurgery

Volumn 86, Issue 3, 2008, Pages 184-186

  Jabre, Mazen ^a,b   Nohra, George ^a,c   Damier, Philippe ^d   Bejjani, Boulos Paul ^a,c  

^a Notre Dame des Secours Hospital   (Lebanon)

^b LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^c HOLY SPIRIT UNIVERSITY OF KASLIK USEK   (Lebanon)

^d NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Dopamine; Neuroleptic; Parkinson's disease; Subthalamic stimulation; Subthalamic stimulation neuroleptic interaction

Indexed keywords

CABERGOLINE; DEXAMETHASONE; DEXCHLORPHENIRAMINE; DOPAMINE; FLUPHENAZINE; LEVODOPA;

ADULT; ALLERGIC REACTION; ANAMNESIS; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; MALE; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NEUROTRANSMISSION; PARKINSON DISEASE; PULSE GENERATOR; QUALITY OF LIFE; SCORING SYSTEM; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; DEEP BRAIN STIMULATION; DOPAMINE; DOPAMINE ANTAGONISTS; HUMANS; MALE; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 43649086810     PISSN: 10116125     EISSN: None     Source Type: Journal    
DOI: 10.1159/000126941     Document Type: Article

References (13)

1. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL: Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-1111.
2. Bejjani BP, Dormont D, Pidoux B, Yelnik J, Damier P, Arnulf I, Bonnet AM, Marsault C, Agid Y, Philippon J, Cornu P: Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiologic guidance. J Neurosurg 2000;92:615-625.
3. Bergmann O, Winter C, Meissner W, Harnack D, Kupch A, Morgenstern R, Reum T: Subthalamic high frequency stimulation induced rotations are differentially medicated by D1 and D2 receptors. Neuropharmacology 2004;46:974-983.
4. Bruet N, Windels F, Carcenac C, Feuerstein C, Bertrand A, Poupard A, Savasta M: Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats. J Neuropathol Exp Neurol 2003;62:1228-1240.
5. Lee KH, Chang SY, Roberts DW, Kim U: Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. J Neurosurg 2004;101:511-517.
6. Oueslati A, Sgambato-Faure V, Melon C, Kichidian P, Gubellini P, Amri M, Kerkerian-Le Goff L, Salin P: High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease. J Neurosci 2007;27:2377-2386.
7. Ibanez-Sandoval O, Hernandez A, Floran B, Galarraga G, Tapia D, Valdiosera R, Erlij D, Aceves J, Bargas J: Control of the subthalamic innervation of substantia nigra pars reticulate by D1 and D2 dopamine receptors. J Neurophysiol 2006;95:1800-1811.
8. Hernandez A, Ibanez-Sandoval O, Sierra A, Valdiosera R, Tapia D, Anaya V, Galarraga E, Bargas J, Aceves J: Control of the subthalamic innervation of the rat globus pallidus by D2/3 and D4 dopamine receptors. J Neurophysiol 2006;96:2877-2888.
9. Parry TJ, Eberle-Wang K, Lucki I, Chesselet MF: Dopaminergic stimulation of subthalamic nucleus elicits oral dykinesia in rats. Exp Neurol 1994;128:181-190.
10. 11C]- raclopride PET study. J Neurol 2003;250:1219-1223.
11. Abosch A, Kapur S, Lang AE, Hussey D, Sime E, Miyasaki J, Houle S, Lozano AM: Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Neurosurgery 2003;53:1095-1102.
12. Hollerman JR, Grace AA: Subthalamic nucleus cell firing in the 6-OHDA-treated rats: basal activity and response to haloperidol. Brain Res 1992;590:291-299.
13. Thobois S, Vingerhoets F, Fraix V, Xie-Brustolin J, Mollion H, Costes N, Mertens P, Benabid AL, Pollak P, Broussolle E: Role of dopaminergic treatment of dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study. Arch Neurol 2004;61:1705-1709.